- Home
- SXTC vs IGA Comparison
SXTC vs IGA Comparison
Compare SXTC & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SXTC | IGA |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.7M | 151.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SXTC | IGA |
|---|---|---|
| Price | $0.09 | $9.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 21.4M | 42.3K |
| Earning Date | 08-19-2019 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,537,987.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.09 | $7.77 |
| 52 Week High | $7.84 | $8.88 |
Technical Indicators
Market Signals| Indicator | SXTC | IGA |
|---|---|---|
| Relative Strength Index (RSI) | 23.90 | 52.31 |
| Support Level | $0.09 | $9.74 |
| Resistance Level | $6.98 | $9.86 |
| Average True Range (ATR) | 0.58 | 0.08 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 0.08 | 43.92 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.